Membership

Categories

View All
Autoimmune Diseases Brain Health Cardiovascular Health Metals Microbes Women’s Health

Conditions

View All
Alzheimer’s Dementia Anemia Autism spectrum disorder (ASD) Bacterial Vaginosis Breast Cancer Chronic Pelvic Pain (CPP) Diabetes Type I Endometriosis Erectile Dysfunction Graves Disease Hashimoto’s Thyroiditis Heart Failure Infertility Irritable Bowel Syndrome (IBS) Parkinson’s Disease

Definitions

View All
Amsel Criteria Blood-Brain Barrier (BBB) Bradford Hill Criteria Coelomic Metaplasia Theory Drug Repurposing  Endometriomas Environmental Theory of Endometriosis Estrobolome Estrogen Estrogen Receptors (ER) Facultative Anaerobes Fecal Microbiota Transplantation (FMT) Genetic and Epigenetic Theory of Disease Gram-Negative Bacteria Idiopathic

Guides & Resources

View All
Endometriosis Guide Microbiome Diet for Endometriosis

Interventions

View All
Boric Acid Cholestyramine Clindamycin Clinoptilolite Zeolite Dimethylglyoxime (DMG) Hyperbaric Oxygen Therapy (HBOT) Lactoferrin Low‑Nickel Diet (LNiD) Lugdunin Metformin Metronidazole Phage Therapy Photobiomodulation Probiotics Tinidazole

Supplements

View All
Essential Oils Flavones and Flavonols Guar Gum Pueraria Flower Extract (PFE)

Microbes

View All
Escherichia coli (E. coli) H pylori Pseudomonas aeruginosa Staphylococcus aureus (S. Aureus) Streptococcus agalactiae (GBS) Streptococcus spp. Ureaplasma urealyticum (U. urealyticum)

Metals

View All
Gallium Metalloestrogens Nickel Nickel in Escherichia coli: Metabolic and Pathogenic Roles Zinc

Research Feeds

View All
Maternal Iron Deficiency Anemia Affects Postpartum Emotions and Cognition Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review Pelvic inflammatory disease: a family practice perspective Microbiology profile in women with pelvic inflammatory disease in relation to IUD use Epidermiological markers in pelvic inflammatory disease (PID) among the women of reproductive age group Bacterial isolates associated with pelvic inflammatory disease among female patients attending some hospitals in abuja, Nigeria The Key Element Role of Metallophores in the Pathogenicity and Virulence of Staphylococcus aureus: A Review The relationship between serum calprotectin levels and disease activity in patients with subacute thyroiditis. 919 Syrup Alleviates Postpartum Depression by Modulating the Structure and Metabolism of Gut Microbes and Affecting the Function of the Hippocampal GABA/Glutamate System Gut microbiota: Linking nutrition and perinatal depression The role of gut microbiota and blood metabolites in postpartum depression: A Mendelian randomization analysis. Association between dietary trace minerals and pelvic inflammatory disease: Data from the 2015–2018 National Health and Nutrition Examination Surveys Association between dietary magnesium intake and pelvic inflammatory disease in US women: a cross-sectional study of NHANES Integrated Metabolomics and Network Pharmacology Study on the Mechanism of Kangfuxiaoyan Suppository for Treating Chronic Pelvic Inflammatory Disease Treatment of postpartum depression: Clinical, psychological and pharmacological options

Posts tagged with "Parkinson's disease" (A-Z)

A C D E F G I M N P R S T
A
A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson’s disease
Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease
Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease
Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
Altered gut microbiota in Parkinson’s disease patients with motor complications
Altered gut microbiota in patients with idiopathic Parkinson’s disease: an age-sex matched case-control study
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Analysis of the Gut Microflora in Patients With Parkinson’s Disease
C
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes
Cross-Sectional Study on the Gut Microbiome of Parkinson’s Disease Patients in Central China
D
Differences in the Composition of Gut Microbiota between Patients with Parkinson’s Disease and Healthy Controls: A Cohort Study
Dysbiosis of gut microbiota in a selected population of Parkinson’s patients
Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson’s disease
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson’s Disease from India
E
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
Evaluation of fecal microbiota transplantation in Parkinson’s disease patients with constipation
Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson’s disease based on metagenomic sequencing
F
Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson’s disease mouse model via modulating gut microbiota and metabolic homeostasis
G
Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease
Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson’s Disease
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
Gut microbiota in Parkinson’s disease: Temporal stability and relations to disease progression
Gut microbiota in patients with Parkinson’s disease in southern China
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson’s disease
I
Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain
Integrated Multi-Cohort Analysis of the Parkinson’s Disease Gut Metagenome
M
Metagenome-assembled microbial genomes from Parkinson’s disease fecal samples
Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson’s Disease
More than constipation – bowel symptoms in Parkinson’s disease and their connection to gut microbiota
N
Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
P
Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome
Parkinson’s Disease and the Gut Microbiome in Rural California
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
R
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
S
Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson’s disease
T
The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson’s disease
The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
The impact of intestinal microbiota on weight loss in Parkinson’s disease patients: a pilot study
The link between increased Desulfovibrio and disease severity in Parkinson’s disease
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Yes, I want to help shape the future of microbiome medicine.